Skip to content

Quality of Life in Patients who underwent radiotherapy

Quality of Life in Patients undergoing Radiotherapy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-97bp3c
Enrollment
Unknown
Registered
2014-06-10
Start date
2010-03-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neoplasm, radiation, motor activity, quality of life

Interventions

"Experimental group: 10 cancer patient during radiotherapy, conduct program of physical exercise under supervision and attend lectures. Control Group: 10 cancer patients during radiotherapy, conduct p
Other
F01.145.632

Sponsors

Hospital do Câncer de Muriaé
Lead Sponsor
Rhayssa Espósito
Collaborator

Eligibility

Age
30 Years to 80 Years

Inclusion criteria

Inclusion criteria: Cancer patients undergoing radiation treatment, both genders, aged 30 to 80 years.

Exclusion criteria

Exclusion criteria: Patients with motor change that prevented them from practicing the activities planned; severe to moderate anemia, bone metastases, severe thrombocytopenia, diabetes, severe heart disease, severe lung disease, with active infections; oxygen saturation less than or equal to 80% in the walk test 6 minutes.

Design outcomes

Primary

MeasureTime frame
Improves the quality of life measured by the SF-36 questionnaire, validated in Portuguese, at baseline and at the end of 20 sessions for individuals in the intervention group and the control group.

Secondary

MeasureTime frame
Improves cardiovascular conditioning observed across the distance traveled by the test 6-minute walk. Was performed at baseline and after 20 sessions in both groups (control and intervention);Improves flexibility assessed by testing normalflex. Was performed at baseline and after 20 sessions in both groups (control and intervention);Need for hospitalization during the study, noted in daily tracking sheet.;Presence of complications during the study as deep vein thrombosis, pneumonia, muscle pain, infection, injury to soft tissue (ligament, muscle and joint), and thus recorded in daily monitoring.

Countries

Brazil

Contacts

Public ContactRhayssa Santos Campos

Hospital do Câncer de Muriaé

rhayssaesposito@yahoo.com.br55 (32) 3722-2580

Outcome results

None listed

Source: REBEC (via WHO ICTRP)